CSN1S1

gene
On this page

Summary

CSN1S1 (casein alpha s1, HGNC:2445) is a protein-coding gene on chromosome 4q13.3, encoding Alpha-S1-casein (P47710). Important role in the capacity of milk to transport calcium phosphate.

Predicted to be involved in several processes, including response to 11-deoxycorticosterone; response to dehydroepiandrosterone; and response to progesterone. Located in extracellular space.

Source: NCBI Gene 1446 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 27 total
  • MANE Select transcript: NM_001890

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:2445
Approved symbolCSN1S1
Namecasein alpha s1
Location4q13.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000126545
Ensembl biotypeprotein_coding
OMIM115450
Entrez1446

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 8 protein_coding

ENST00000246891, ENST00000505782, ENST00000507763, ENST00000507772, ENST00000510936, ENST00000633258, ENST00000949200, ENST00000949201

RefSeq mRNA: 2 — MANE Select: NM_001890 NM_001025104, NM_001890

CCDS: CCDS47067, CCDS54769

Canonical transcript exons

ENST00000246891 — 16 exons

ExonStartEnd
ENSE000008652116994253669942577
ENSE000010245356994002169940044
ENSE000010245556993254469932606
ENSE000010245586993106869931117
ENSE000010245596993421269934244
ENSE000010245616993780069937823
ENSE000010245626993712169937144
ENSE000010245646993917669939208
ENSE000011712786993656669936607
ENSE000011712856993645669936479
ENSE000011712926993592669935949
ENSE000011713006993469069934710
ENSE000017055516994619669946574
ENSE000024542196994204669942063
ENSE000027007416994485069945004
ENSE000037885706994101969941060

Expression profiles

Bgee: expression breadth ubiquitous, 124 present calls, max score 89.45.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1124 / max 47.6216, expressed in 13 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
478450.112413

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.45gold quality
parotid glandUBERON:000183176.26silver quality
layer of synovial tissueUBERON:000761674.45gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099171.67gold quality
synovial jointUBERON:000221768.96gold quality
adipose tissueUBERON:000101368.45gold quality
subcutaneous adipose tissueUBERON:000219067.07gold quality
connective tissueUBERON:000238466.83gold quality
skin of hipUBERON:000155466.39silver quality
thoracic mammary glandUBERON:000520061.63gold quality
mammary glandUBERON:000191161.56gold quality
cingulate cortexUBERON:000302760.86gold quality
anterior cingulate cortexUBERON:000983560.53gold quality
diaphragmUBERON:000110358.41gold quality
adipose tissue of abdominal regionUBERON:000780858.23gold quality
epithelium of mammary glandUBERON:000324457.91silver quality
mammary ductUBERON:000176557.61silver quality
omental fat padUBERON:001041456.89gold quality
peritoneumUBERON:000235856.84gold quality
amniotic fluidUBERON:000017356.59silver quality
endometrium epitheliumUBERON:000481153.13gold quality
pancreatic ductal cellCL:000207953.05silver quality
mucosa of transverse colonUBERON:000499152.06gold quality
lower lobe of lungUBERON:000894951.94silver quality
vermiform appendixUBERON:000115451.28gold quality
mucosa of urinary bladderUBERON:000125951.28gold quality
frontal poleUBERON:000279550.41gold quality
quadriceps femorisUBERON:000137750.30gold quality
middle frontal gyrusUBERON:000270250.30gold quality
paraflocculusUBERON:000535150.18gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-MTAB-10885yes54899.83
E-MTAB-10855yes52657.44
E-MTAB-9841yes47918.63
E-ANND-3yes4.39

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CEBPG, DNMT1, FOXC1, JUN, STAT5A, STAT5B

miRNA regulators (miRDB)

28 targeting CSN1S1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-365899.9673.874379
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-391999.8769.452489
HSA-MIR-806799.8669.592260
HSA-MIR-132399.8369.892471
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-26A-1-3P99.6466.81788
HSA-MIR-26A-2-3P99.6466.82786
HSA-MIR-312899.5067.851258
HSA-MIR-32-3P99.3668.202517
HSA-MIR-888-5P99.3070.151855
HSA-MIR-442699.1766.741949
HSA-MIR-478499.1567.411733
HSA-MIR-314698.8566.77601
HSA-MIR-3150B-3P98.8167.211728
HSA-MIR-429098.5165.17907
HSA-MIR-4720-3P98.5068.88988
HSA-MIR-4662B98.3366.371163
HSA-MIR-464798.3066.411139
HSA-MIR-5579-3P97.0068.811111
HSA-MIR-3059-3P96.7167.08606
HSA-MIR-393596.3366.79797
HSA-MIR-2276-5P96.2765.85937
HSA-MIR-7848-3P95.6965.00363

Literature-anchored findings (GeneRIF, showing 4)

  • alphas1-Casein may be a potential biomarker for early identification of BPH patients. (PMID:16683014)
  • Casein alpha s1 is expressed in human monocytes and stimulates expression of proinflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) via an immunomodulatory role beyond the nutritional function of CSN1S1 in milk. (PMID:21135174)
  • Results suggest that autoimmunity to insulin can occur infrequently via cross-reactivity to food protein alpha casein. (PMID:21361910)
  • Serine-71 in alpha-S1 casein is phosphorylated in the breast milk. (PMID:28786558)

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusCsn1s1ENSMUSG00000070702

Protein

Protein identifiers

Alpha-S1-caseinP47710 (reviewed: P47710)

All UniProt accessions (5): P47710, A0A0J9YVR3, D6RF34, E9PDQ1, H0Y8K1

UniProt curated annotations — full annotation on UniProt →

Function. Important role in the capacity of milk to transport calcium phosphate. Casoxin D acts as opioid antagonist and has vasorelaxing activity mediated by bradykinin B1 receptors.

Subunit / interactions. Heteromultimers of alpha-s1 casein and kappa-casein; disulfide-linked.

Subcellular location. Secreted.

Tissue specificity. Mammary gland specific. Secreted in milk.

Post-translational modifications. Not glycosylated.

Miscellaneous. In milk, the alpha s1- and beta-caseins precipitate in presence of calcium (so-called calcium-sensitive caseins). Kappa-casein prevents the precipitation of the other caseins by calcium through the formation of large stable colloidal particles termed micelles.

Similarity. Belongs to the alpha-casein family.

Isoforms (4)

UniProt IDNamesCanonical?
P47710-11yes
P47710-22
P47710-33
P47710-44

RefSeq proteins (2): NP_001020275, NP_001881* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026999Alpha-s1_caseinFamily
IPR031305Casein_CSConserved_site

UniProt features (18 total): modified residue 10, splice variant 3, signal peptide 1, chain 1, sequence variant 1, sequence conflict 1, peptide 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P47710-F162.570.05

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (10): 89, 90, 91, 31, 33, 41, 71, 85, 86, 88

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-5223345Miscellaneous transport and binding events
R-HSA-382551Transport of small molecules

MSigDB gene sets: 47 (showing top): GOBP_RESPONSE_TO_ESTRADIOL, GOBP_RESPONSE_TO_CORTICOSTEROID, chr4q13, GOBP_RESPONSE_TO_KETONE, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MODULE_99, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, OCT1_07, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, TGANTCA_AP1_C, GOBP_RESPONSE_TO_STEROID_HORMONE, GOBP_RESPONSE_TO_HORMONE, GOBP_RESPONSE_TO_LIPID, GOBP_RESPONSE_TO_PROGESTERONE, GOBP_RESPONSE_TO_MINERALOCORTICOID

GO Biological Process (4): response to estradiol (GO:0032355), response to progesterone (GO:0032570), response to dehydroepiandrosterone (GO:1903494), response to 11-deoxycorticosterone (GO:1903496)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
response to ketone3
response to lipid2
response to alcohol2
response to oxygen-containing compound1
response to steroid hormone1
response to mineralocorticoid1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

652 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CSN1S1CSN2P05814999
CSN1S1CSN3P07498998
CSN1S1LALBAP00709950
CSN1S1LTFP02788664
CSN1S1PRLP01236652
CSN1S1ALBP02768648
CSN1S1STAT5AP42229572
CSN1S1BTN1A1Q13410544
CSN1S1DGAT1O75907520
CSN1S1STAT5BP51692518
CSN1S1STATHP02808514
CSN1S1PIGRP01833510
CSN1S1TFP02787498
CSN1S1PAEPP09466497
CSN1S1EFSO43281488

IntAct

11 interactions, top by confidence:

ABTypeScore
CSN1S1UBQLN2psi-mi:“MI:0915”(physical association)0.560
KIF1CKIF1Bpsi-mi:“MI:2364”(proximity)0.480
CSN1S1KLK6psi-mi:“MI:0570”(protein cleavage)0.440
CUL4ADDX39Apsi-mi:“MI:0914”(association)0.350
CSN1S1TIMP3psi-mi:“MI:0914”(association)0.350
CSN1S1KLHL15psi-mi:“MI:0914”(association)0.350
ZFP36L1CNOT1psi-mi:“MI:2364”(proximity)0.270
CSN1S1UBQLN2psi-mi:“MI:0915”(physical association)0.000
TOLLIPCSN1S1psi-mi:“MI:0915”(physical association)0.000

BioGRID (43): PDE10A (Affinity Capture-MS), B4GALNT4 (Affinity Capture-MS), LTBP1 (Affinity Capture-MS), EMILIN3 (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), TIMP3 (Affinity Capture-MS), ERF (Affinity Capture-MS), BCOR (Affinity Capture-MS), CDKN2AIP (Affinity Capture-MS), FAM120A (Affinity Capture-MS), ETV3 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS)

ESM2 similar proteins: A1E959, A1E960, A1YQ91, A1YQ92, A1YQ93, A1YQ94, B3A0S0, B4H957, B5DRT7, O55189, O62823, P02662, P02665, P02668, P02669, P02670, P04653, P04656, P06796, P11840, P11841, P18626, P19228, P33618, P39035, P39037, P42155, P42156, P42157, P47710, P50420, P50421, P50422, P50423, P50424, P50425, P79139, P82187, P86273, Q003G9

Diamond homologs: O62823, O97943, P02662, P04653, P04656, P09115, P18626, P39035, P47710, P86272, P19228, P02661

SIGNOR signaling

1 interactions.

AEffectBMechanism
CSN1S1up-regulatesRELAphosphorylation

Disease & clinical

Clinical variants and AI predictions

ClinVar

27 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2020 predictions. Top by Δscore:

VariantEffectΔscore
4:69942575:GTG:Gdonor_gain1.0000
4:69944848:A:AGacceptor_gain1.0000
4:69944848:AGC:Aacceptor_loss1.0000
4:69944849:G:GTacceptor_gain1.0000
4:69944849:GC:Gacceptor_gain1.0000
4:69944849:GCC:Gacceptor_gain1.0000
4:69944849:GCCT:Gacceptor_gain1.0000
4:69944849:GCCTT:Gacceptor_gain1.0000
4:69945002:GTG:Gdonor_gain1.0000
4:69932602:GGCCT:Gdonor_gain0.9900
4:69932603:GCCTG:Gdonor_gain0.9900
4:69932612:T:Gdonor_gain0.9900
4:69934819:A:Gacceptor_gain0.9900
4:69935108:T:Gacceptor_gain0.9900
4:69936478:GG:Gdonor_gain0.9900
4:69936479:GG:Gdonor_gain0.9900
4:69937798:A:Gacceptor_gain0.9900
4:69939174:A:AGacceptor_gain0.9900
4:69939175:G:GGacceptor_gain0.9900
4:69939175:GAA:Gacceptor_gain0.9900
4:69942531:TGCA:Tacceptor_loss0.9900
4:69942532:GCA:Gacceptor_loss0.9900
4:69942533:CA:Cacceptor_loss0.9900
4:69942534:A:ATacceptor_loss0.9900
4:69942535:G:GAacceptor_loss0.9900
4:69942570:TCC:Tdonor_gain0.9900
4:69944832:AAAT:Aacceptor_gain0.9900
4:69945000:TGGTG:Tdonor_gain0.9900
4:69945001:GGTG:Gdonor_gain0.9900
4:69945001:GGTGG:Gdonor_gain0.9900

AlphaMissense

1238 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:69932577:T:CC8R0.985
4:69944895:T:AW150R0.958
4:69944895:T:CW150R0.958
4:69932587:C:AA11D0.957
4:69932593:C:AA13D0.946
4:69944897:G:CW150C0.934
4:69944897:G:TW150C0.934
4:69932599:C:AA15D0.931
4:69932590:T:AV12D0.918
4:69945000:T:AW185R0.908
4:69945000:T:CW185R0.908
4:69932581:T:AL9H0.907
4:69932584:T:AV10E0.902
4:69932596:T:CL14P0.895
4:69932581:T:CL9P0.894
4:69932586:G:CA11P0.875
4:69932569:T:AI5N0.872
4:69932579:T:GC8W0.864
4:69932569:T:CI5T0.858
4:69932581:T:GL9R0.857
4:69932592:G:CA13P0.847
4:69932596:T:AL14H0.846
4:69944937:T:CF164L0.842
4:69944939:T:AF164L0.842
4:69944939:T:GF164L0.842
4:69932598:G:CA15P0.835
4:69932578:G:AC8Y0.832
4:69944928:T:CF161L0.830
4:69944930:C:AF161L0.830
4:69944930:C:GF161L0.830

dbSNP variants (sampled 300 via entrez): RS1000188149 (4:69931453 A>G), RS1000240586 (4:69931181 G>C,T), RS10002549 (4:69945254 G>A), RS1000382011 (4:69937313 A>C), RS1000525768 (4:69930186 A>G), RS1000582937 (4:69929907 C>A), RS1000692304 (4:69935698 A>G), RS1000753182 (4:69936933 T>C), RS1000831959 (4:69941862 G>A), RS10009308 (4:69930020 C>T), RS10011226 (4:69935723 C>A,T), RS1001322307 (4:69931047 C>T), RS1001371204 (4:69930758 T>C), RS1001681043 (4:69943134 G>A), RS1001862993 (4:69935418 C>T)

Disease associations

OMIM: gene MIM:115450 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamideincreases expression1
zomepirac glucuronideaffects binding1
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, increases expression1
2-palmitoylglycerolincreases expression1
bisphenol Sdecreases methylation, affects cotreatment1
Fulvestrantaffects cotreatment, decreases methylation1
Azacitidineincreases expression1
Benzo(a)pyrenedecreases methylation1
Lipopolysaccharidesaffects cotreatment, increases expression1
Nickelincreases expression1
Aflatoxin B1decreases methylation1
Sodium Selenitedecreases expression1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.